R&D Changing Faces – Board of Directors and Advisory Boards - Oc... From high-profile resignations to the addition of seasoned executives and scientific leaders, last month saw a series of notable changes.
Digital Changing Faces – Digital and supplier hires - October 2025 In the digital and supplier space, we saw a good deal of personnel movement in October, including a number of CEO appointments.
R&D Changing Faces - Pharma and biotech - October 2025 From high-profile resignations to strategic appointments, October was a buzzy month for pharma industry personnel news.
R&D Changing Faces – Boards of Directors and Advisory Boards – A... Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to report on.
Sales & Marketing Changing Faces – Agency, investor, and legal hires – August ... In the agency and investor worlds, August and September hires were light volume-wise, but did include big changes at the top of the totem pole.
Digital Changing Faces – Digital and supplier hires – August and Sep... There was plenty of personnel action in August and September among pharmaceutical suppliers, particularly in the clinical trial technology sector.
News Ambros' $125m for pain disorder drug, and other financings Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.